|Articles|March 1, 2021
Entegris, Inc.
Author(s)Entegris
At Entegris, our 50+ years of proven materials science experience in the most demanding industries allowed us to easily become a strategic life sciences partner and today play a crucial role in development and manufacture of vaccine therapies. We combine product innovation with quick-turn customization to deliver critical solutions to meet your bioprocess needs.
Entegris, Inc.
129 Concord Road, Billerica, MA 01821 USA
Tel.+1.978.436.6500
Fax +1.978.436.6735
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
